Moxifloxacin enhances antiproliferative and apoptotic effects of etoposide but inhibits its proinflammatory effects in THP-1 and Jurkat cells

Etoposide (VP-16) is a topoisomerase II (topo II) inhibitor chemotherapeutic agent. Studies indicate that VP-16 enhances proinflammatory cytokines secretion from tumour cells, including IL-8, a chemokine associated with proangiogenic effects. Fluoroquinolones inhibit topo II activity in eukaryotic c...

Descripción completa

Detalles Bibliográficos
Autores principales: Fabian, I, Reuveni, D, Levitov, A, Halperin, D, Priel, E, Shalit, I
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2006
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360706/
https://www.ncbi.nlm.nih.gov/pubmed/17047652
http://dx.doi.org/10.1038/sj.bjc.6603355

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360706/
https://www.ncbi.nlm.nih.gov/pubmed/17047652
http://dx.doi.org/10.1038/sj.bjc.6603355

Ejemplares similares